{"classification":"Class II","center_classification_date":"2020-08-29","report_date":"2020-09-09","postal_code":"51579-1503","termination_date":"2022-09-17","recall_initiation_date":"2020-07-16","recall_number":"D-1558-2020","city":"Woodbine","more_code_info":"uau","event_id":86233,"distribution_pattern":"One direct account in UT","openfda_application_number":"nan","openfda_brand_name":"['HGH VITALITY']","openfda_dosage_form":null,"openfda_generic_name":"['AGNUS CASTUS, AMBRA GRISEA, APIOLUM, ESTRADIOL, ESTRIOL, L-DOPA, MELATONIN, TESTOSTERONE, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-LIPOICUM ACIDUM, NADIDUM, PANTOTHENIC ACID, SARCOLACTICUM ACIDUM, UBIDECARENONUM, BARYTA CARBONICA, CONIUM MACULATUM, SELENIUM METALLICUM, FOLLICULINUM, FUNICULUS UMBILICALIS SUIS, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HYPOTHALAMUS (SUIS), LYMPH NODE (SUIS), MEDULLA OSSIS SUIS, OOPHORINUM (SUIS), ORCHITINUM (SUIS), PANCREAS SUIS, SPLEEN (SUIS), HUMAN GROWTH HORMONE, PROTEUS']","openfda_manufacturer_name":"['Deseret Biologicals']","openfda_product_ndc":"['43742-1299']","openfda_product_type":"['HUMAN OTC DRUG']","openfda_route":"['ORAL']","openfda_substance_name":"['.ALPHA.-LIPOIC ACID', 'ADENOSINE TRIPHOSPHATE DISODIUM', 'AMBERGRIS', 'APIOLE (PARSLEY)', 'BARIUM CARBONATE', 'CHASTE TREE', 'CONIUM MACULATUM FLOWERING TOP', 'ESTRADIOL', 'ESTRIOL', 'ESTRONE', 'LACTIC ACID, L-', 'LEVODOPA', 'MELATONIN', 'NADIDE', 'PANTOTHENIC ACID', 'PORK LIVER', 'PROTEUS MORGANII', 'SELENIUM', 'SOMATROPIN', 'SUS SCROFA ADRENAL GLAND', 'SUS SCROFA BONE MARROW', 'SUS SCROFA HYPOTHALAMUS', 'SUS SCROFA LYMPH', 'SUS SCROFA OVARY', 'SUS SCROFA PANCREAS', 'SUS SCROFA SPLEEN', 'SUS SCROFA TESTICLE', 'SUS SCROFA UMBILICAL CORD', 'TESTOSTERONE', 'UBIDECARENONE']","openfda_spl_id":"['bd2c1674-96dd-48f9-b2ba-e2054169406c']","openfda_spl_set_id":"['85423368-892c-4bd6-823e-033201462c76']","openfda_pharm_class_moa":"['Estrogen Receptor Agonists [MoA]', 'Androgen Receptor Agonists [MoA]']","openfda_pharm_class_cs":"['Estradiol Congeners [CS]', 'Amino Acids, Aromatic [CS]', 'Human Growth Hormone [CS]', 'Androstanes [CS]']","openfda_pharm_class_pe":"nan","openfda_pharm_class_epc":"['Estrogen [EPC]', 'Aromatic Amino Acid [EPC]', 'Recombinant Human Growth Hormone [EPC]', 'Androgen [EPC]']","openfda_upc":"nan","openfda_unii":"['73Y7P0K73Y', '5L51B4DR1G', 'XTC0D02P6C', 'QQ67504PXO', '6P669D8HQ8', '433OSF3U8A', 'Q28R5GF371', '4TI98Z838E', 'FB33469R8E', '2DI9HA706A', 'F9S9FFU82N', '46627O600J', 'JL5DK93RCL', '0U46U6E8UK', '19F5HK2737', '6EC706HI7F', '56X6LID5ZY', 'H6241UJ22B', 'NQX9KB6PCL', '398IYQ16YV', 'VP2CN2G7Y8', 'N6R0856Z79', '33A7VYU29L', 'S7YTV04R8O', '9Y3J3362RY', '92AMN5J79Y', 'KM02613O28', '118OYG6W3H', '3XMK78S47O', 'EJ27X76M46']","openfda_rxcui":"(nan","recalling_firm":"Grato Holdings, Inc.","voluntary_mandated":"Voluntary: Firm initiated","state":"IA","reason_for_recall":"Labeling: Error on Declared Strength","initial_firm_notification":"E-Mail","status":"Terminated","product_type":"Drugs","country":"United States","product_description":"HGH Vitality Homeopathic, 90 tablets, NDC 43742-1299-1, Dist. by Deseret Biologicals, Inc. 469 W. Parkland Drive, Sandy, UT 84070, NDC: 43742-1299-1","code_info":"Lot P2613","address_1":"201 Apple Blvd","address_2":"nan","product_quantity":"850 bottles"}
{"classification":"Class III","center_classification_date":"2013-08-16","report_date":"2013-08-28","postal_code":"30024-6056","termination_date":"2014-05-27","recall_initiation_date":"2013-06-28","recall_number":"D-897-2013","city":"Suwanee","more_code_info":"uau","event_id":65663,"distribution_pattern":"Nationwide.","openfda_application_number":"nan","openfda_brand_name":"['NATACHEW']","openfda_dosage_form":null,"openfda_generic_name":"['.BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, D-, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, IRON, NIACINAMIDE']","openfda_manufacturer_name":"['Eckson Labs, LLC']","openfda_product_ndc":"['44118-902']","openfda_product_type":"['HUMAN PRESCRIPTION DRUG']","openfda_route":"['ORAL']","openfda_substance_name":"['.ALPHA.-TOCOPHEROL ACETATE, D-', '.BETA.-CAROTENE', 'ASCORBIC ACID', 'CHOLECALCIFEROL', 'CYANOCOBALAMIN', 'FOLIC ACID', 'IRON', 'NIACINAMIDE', 'PYRIDOXINE HYDROCHLORIDE', 'RIBOFLAVIN', 'THIAMINE MONONITRATE']","openfda_spl_id":"['04c70780-c6d6-8843-e063-6394a90a7caf']","openfda_spl_set_id":"['043f8497-8bb3-4604-84eb-d463ef25f724']","openfda_pharm_class_moa":"nan","openfda_pharm_class_cs":"['Ascorbic Acid [CS]', 'Vitamin D [CS]', 'Vitamin B 12 [CS]']","openfda_pharm_class_pe":"nan","openfda_pharm_class_epc":"['Vitamin C [EPC]', 'Vitamin D [EPC]', 'Vitamin B12 [EPC]']","openfda_upc":"nan","openfda_unii":"['A7E6112E4N', 'PQ6CK8PD0R', '1C6V77QF41', 'P6YC3EG204', '935E97BOY8', 'E1UOL152H7', '25X51I8RD4', '68Y4CF58BV', 'TLM2976OFR', '8K0I04919X']","openfda_rxcui":"(nan","recalling_firm":"Stayma Consulting Service, LLC.","voluntary_mandated":"Voluntary: Firm initiated","state":"GA","reason_for_recall":"Subpotent; Beta carotene (Vitamin A)","initial_firm_notification":"Letter","status":"Terminated","product_type":"Drugs","country":"United States","product_description":"NataChew, 1) one 90-count bottle of multi-vitamin tablets (imprinted 902), (NDC 44118-902-90) and 2) physician samples containing nine bottles with 5 multi-vitamin tablets (imprinted 902) (NDC 44118-902-05), Manufactured for Eckson Labs, Wilmington, DE","code_info":"1) Lot 41065, exp 10/14 and 41099, exp 9/14 NDC 44118-902-90                                                                                         2) Lot 41065A, exp. 9/14 NDC 44118-902-05","address_1":"5400 Laurel Springs Pkwy","address_2":"Suite 803","product_quantity":"1) 4546 bottles and 2) 1349 bottles"}
{"classification":"Class II","center_classification_date":"2021-05-24","report_date":"2021-06-02","postal_code":"43017-1091","termination_date":null,"recall_initiation_date":"2021-03-15","recall_number":"D-0496-2021","city":"Dublin","more_code_info":"uau","event_id":87512,"distribution_pattern":"FL, GA, SC","openfda_application_number":"nan","openfda_brand_name":"['ENBRACE HR']","openfda_dosage_form":null,"openfda_generic_name":"['LEVOMEFOLATE MAGNESIUM, LEUCOVORIN, FOLIC ACID, FERROUS CYSTEINE GLYCINATE, MAGNESIUM ASCORBATE, ZINC ASCORBATE, COCARBOXYLASE, FLAVIN ADENINE DINUCLEOTIDE, NADH, PYRIDOXAL PHOSPHATE ANHYDROUS, COBAMAMIDE, BETAINE, MAGNESIUM L-THREONATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, AND PHOSPHATIDYL SERINE']","openfda_manufacturer_name":"['Jaymac Pharma']","openfda_product_ndc":"['64661-650']","openfda_product_type":"['HUMAN PRESCRIPTION DRUG']","openfda_route":"['ORAL']","openfda_substance_name":"['1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM', '1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM', 'BETAINE', 'COBAMAMIDE', 'COCARBOXYLASE', 'FERROUS CYSTEINE GLYCINATE', 'FLAVIN ADENINE DINUCLEOTIDE', 'FOLIC ACID', 'LEUCOVORIN', 'LEVOMEFOLATE MAGNESIUM', 'MAGNESIUM ASCORBATE', 'MAGNESIUM L-THREONATE', 'NADH', 'PHOSPHATIDYL SERINE', 'PYRIDOXAL PHOSPHATE ANHYDROUS', 'ZINC ASCORBATE']","openfda_spl_id":"['a5369c78-1e2f-4a51-b3df-6ed5b5478986']","openfda_spl_set_id":"['6f14fa40-97ab-4ec5-b66b-793d6d1abac9']","openfda_pharm_class_moa":"['Methylating Activity [MoA]']","openfda_pharm_class_cs":"['Folic Acid [CS]']","openfda_pharm_class_pe":"nan","openfda_pharm_class_epc":"['Methylating Agent [EPC]', 'Folate Analog [EPC]']","openfda_upc":"['0364661650302']","openfda_unii":"['6WJM73T46K', '9ABD9DRK7B', '3SCV180C9W', 'F0R1QK73KB', 'Q57971654Y', '8B4OP7RK5N', 'ZC44YTI8KK', '935E97BOY8', 'Q573I9DVLP', '1VZZ62R081', '0N1G678593', '1Y26ZZ0OTM', '4J24DQ0916', '394XK0IH40', 'F06SGE49M6', '9TI35313XW']","openfda_rxcui":"(nan","recalling_firm":"Cardinal Health Inc.","voluntary_mandated":"Voluntary: Firm initiated","state":"OH","reason_for_recall":"CGMP Deviations: Intermittent exposure to temperature excursion during storage.","initial_firm_notification":"Letter","status":"Completed","product_type":"Drugs","country":"United States","product_description":"Enbrace HR 30 ct. Softgels Enhanced Prenatal Vitamin Supplement Rx NDC 64661-650-30 Manufactured for: JAYMAC Pharmaceuticals, LLC, Sunset, LA 70584","code_info":"All Lots distributed 02/23/2021 through 03/10/2021.","address_1":"7000 Cardinal Pl","address_2":"nan","product_quantity":"11 bottles"}
{"classification":"Class II","center_classification_date":"2021-05-24","report_date":"2021-06-02","postal_code":"43017-1091","termination_date":null,"recall_initiation_date":"2021-03-15","recall_number":"D-0486-2021","city":"Dublin","more_code_info":"uau","event_id":87512,"distribution_pattern":"FL, GA, SC","openfda_application_number":"['NDA205551']","openfda_brand_name":"['TRIUMEQ']","openfda_dosage_form":null,"openfda_generic_name":"['ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE']","openfda_manufacturer_name":"['ViiV Healthcare Company']","openfda_product_ndc":"['49702-231', '49702-258']","openfda_product_type":"['HUMAN PRESCRIPTION DRUG']","openfda_route":"['ORAL']","openfda_substance_name":"['ABACAVIR SULFATE', 'DOLUTEGRAVIR SODIUM', 'LAMIVUDINE']","openfda_spl_id":"['c6caf251-b34f-4846-a477-576354b96d15']","openfda_spl_set_id":"['2997739a-aa91-42aa-a206-a70e2db7b84f']","openfda_pharm_class_moa":"['Nucleoside Reverse Transcriptase Inhibitors [MoA]']","openfda_pharm_class_cs":"nan","openfda_pharm_class_pe":"nan","openfda_pharm_class_epc":"['Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]', 'Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]']","openfda_upc":"['0349702231139']","openfda_unii":"['J220T4J9Q2', '1Q1V9V5WYQ', '2T8Q726O95']","openfda_rxcui":"(['1546888', '1546894', '2598348', '2598352']","recalling_firm":"Cardinal Health Inc.","voluntary_mandated":"Voluntary: Firm initiated","state":"OH","reason_for_recall":"CGMP Deviations: Intermittent exposure to temperature excursion during storage.","initial_firm_notification":"Letter","status":"Completed","product_type":"Drugs","country":"United States","product_description":"Triumeq (abacavir, dolutegravir, and lamivudine) 600 mg/50 mg/300 mg Tablets 30 Tablets Rx Only NDC 49702-231-13 Manufactured for: Viiv Healthcare Research Triangle Park, NC 27709 by GlaxoSmithKline Research Triangle Park, NC 27709","code_info":"GS5G","address_1":"7000 Cardinal Pl","address_2":"nan","product_quantity":"2264 bottles"}
{"classification":"Class II","center_classification_date":"2012-07-12","report_date":"2012-07-18","postal_code":"27597-1217","termination_date":"2014-09-04","recall_initiation_date":"2012-06-04","recall_number":"D-1412-2012","city":"Zebulon","more_code_info":"uau","event_id":62392,"distribution_pattern":"Nationwide","openfda_application_number":"['NDA021205']","openfda_brand_name":"['TRIZIVIR']","openfda_dosage_form":null,"openfda_generic_name":"['ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE']","openfda_manufacturer_name":"['ViiV Healthcare Company']","openfda_product_ndc":"['49702-217']","openfda_product_type":"['HUMAN PRESCRIPTION DRUG']","openfda_route":"['ORAL']","openfda_substance_name":"['ABACAVIR SULFATE', 'LAMIVUDINE', 'ZIDOVUDINE']","openfda_spl_id":"['82d4603e-fbba-4bf5-8946-b279d775dd46']","openfda_spl_set_id":"['9b32f5a4-d0f7-486b-b699-8dc9202b6869']","openfda_pharm_class_moa":"['Nucleoside Reverse Transcriptase Inhibitors [MoA]']","openfda_pharm_class_cs":"nan","openfda_pharm_class_pe":"nan","openfda_pharm_class_epc":"['Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]', 'Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]']","openfda_upc":"['0349702217188']","openfda_unii":"['J220T4J9Q2', '2T8Q726O95', '4B9XT59T7S']","openfda_rxcui":"(['285028', '307650']","recalling_firm":"GlaxoSmithKline Inc","voluntary_mandated":"Voluntary: Firm initiated","state":"NC","reason_for_recall":"Adulterated Presence of Foreign Tablets: Trizivir 300/150/300 mg tables, Lot 0ZP5128 may incorrectly contain Lexiva 700 mg tablets.","initial_firm_notification":"Letter","status":"Terminated","product_type":"Drugs","country":"United States","product_description":"Trizivir (abacavir sulfate 300mg, lamivudine 150 mg and zidovudine 300 mg), 60 Tablets, Rx only, Manufactured for: ViiV Healthcare, Research Triangle Park, NC 27709 by: GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 49702-217-18","code_info":"Lot #0ZP5128 exp; 8/2013","address_1":"1011 North Arendell Ave","address_2":"P.O. Box 1217","product_quantity":"14,465 bottles"}
{"classification":"Class II","center_classification_date":"2015-05-27","report_date":"2015-06-03","postal_code":"43228-9579","termination_date":"2016-02-19","recall_initiation_date":"2015-04-02","recall_number":"D-1085-2015","city":"Columbus","more_code_info":"uau","event_id":70990,"distribution_pattern":"Nationwide and Puerto Rico","openfda_application_number":"['ANDA078470']","openfda_brand_name":"['ACARBOSE']","openfda_dosage_form":null,"openfda_generic_name":"['ACARBOSE']","openfda_manufacturer_name":"['Hikma Pharmaceuticals USA Inc.']","openfda_product_ndc":"['0054-0140', '0054-0141', '0054-0142']","openfda_product_type":"['HUMAN PRESCRIPTION DRUG']","openfda_route":"['ORAL']","openfda_substance_name":"['ACARBOSE']","openfda_spl_id":"['68881739-6edb-4c67-be06-14953f60a146']","openfda_spl_set_id":"['352dd336-d3f9-4ac5-a000-91d3aef7aca3']","openfda_pharm_class_moa":"['alpha Glucosidase Inhibitors [MoA]']","openfda_pharm_class_cs":"nan","openfda_pharm_class_pe":"nan","openfda_pharm_class_epc":"['alpha-Glucosidase Inhibitor [EPC]']","openfda_upc":"['0300540140250']","openfda_unii":"['T58MSI464G']","openfda_rxcui":"(['199149', '199150', '200132']","recalling_firm":"Boehringer Ingelheim Roxane Inc","voluntary_mandated":"Voluntary: Firm initiated","state":"OH","reason_for_recall":"Subpotent Drug: The firm received an out of specification result for Assay (potency was below specification) at the 9 month stability time point.","initial_firm_notification":"Letter","status":"Completed","product_type":"Drugs","country":"United States","product_description":"Acarbose Tablets 50 mg a)10 x 10 Unit Dose Tablets per Blister Pack, b)100 count Bottles, Rx only, Roxane Laboratories, Inc. Columbus, Ohio 43216, NDC a) 0054-0141-20, b) 0054-0141-25","code_info":"a) Lot # 460073A Exp 04/2016  b) Lot # 460073B  Exp 04/2016","address_1":"1809 Wilson Rd","address_2":"nan","product_quantity":"a) 575 Blister Packs, b) 12,802 Bottles"}
{"classification":"Class III","center_classification_date":"2012-07-19","report_date":"2012-07-25","postal_code":"07960-4526","termination_date":"2014-03-27","recall_initiation_date":"2012-04-26","recall_number":"D-1424-2012","city":"Morristown","more_code_info":"uau","event_id":61948,"distribution_pattern":"Product was distributed to 93 retail accounts/customers.","openfda_application_number":"['part343']","openfda_brand_name":"['MIDOL COMPLETE']","openfda_dosage_form":null,"openfda_generic_name":"['ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE']","openfda_manufacturer_name":"['Bayer HealthCare LLC.']","openfda_product_ndc":"['0280-8005']","openfda_product_type":"['HUMAN OTC DRUG']","openfda_route":"['ORAL']","openfda_substance_name":"['ACETAMINOPHEN', 'CAFFEINE', 'PYRILAMINE MALEATE']","openfda_spl_id":"['fa3ff071-7cb7-a1ee-e053-6394a90aff94']","openfda_spl_set_id":"['ce9e6acb-a38b-4c9b-a7e8-3e1c2a49a324']","openfda_pharm_class_moa":"nan","openfda_pharm_class_cs":"['Xanthines [CS]']","openfda_pharm_class_pe":"['Central Nervous System Stimulation [PE]']","openfda_pharm_class_epc":"['Central Nervous System Stimulant [EPC]', 'Methylxanthine [EPC]']","openfda_upc":"['0312843555198']","openfda_unii":"['362O9ITL9D', '3G6A5W338E', 'R35D29L3ZA']","openfda_rxcui":"(['1597298']","recalling_firm":"Bayer Healthcare, LLC","voluntary_mandated":"Voluntary: Firm initiated","state":"NJ","reason_for_recall":"Labeling: Label Mix-up: This recall was initiated after identifying that the label statement on the blister strip regarding the maximum number of capsules/caplets that should be taken within a 24-hour period, does not match the statement on the carton.","initial_firm_notification":"Letter","status":"Terminated","product_type":"Drugs","country":"United States","product_description":"Midol Complete, Acetaminophen, Caffeine, Pyrilamine Maleate, Caplets, OTC, a) 16 ct. blister (NDC 0280-8005-16), b)24 ct. blister, Distributed by Bayer Health Care, Morristown, NJ 07962 (NDC 0280-8005-25)","code_info":"NAA055N Exp.12/13, NAA05PC Exp.12/13, NAA0462 Exp.12/13","address_1":"36 Columbia Rd","address_2":"nan","product_quantity":"48,528 cartons"}
{"classification":"Class III","center_classification_date":"2012-07-19","report_date":"2012-07-25","postal_code":"07960-4526","termination_date":"2014-03-27","recall_initiation_date":"2012-04-26","recall_number":"D-1423-2012","city":"Morristown","more_code_info":"uau","event_id":61948,"distribution_pattern":"Product was distributed to 93 retail accounts/customers.","openfda_application_number":"['M027']","openfda_brand_name":"['MIDOL COMPLETE']","openfda_dosage_form":null,"openfda_generic_name":"['MIDOL COMPLETE']","openfda_manufacturer_name":"['Bayer HealthCare LLC']","openfda_product_ndc":"['0280-8015']","openfda_product_type":"['HUMAN OTC DRUG']","openfda_route":"['ORAL']","openfda_substance_name":"['ACETAMINOPHEN', 'CAFFEINE', 'PYRILAMINE MALEATE']","openfda_spl_id":"['0b61ed6d-b860-c5fc-e063-6394a90ab2a6']","openfda_spl_set_id":"['0a4477ce-0a02-197d-e054-00144ff88e88']","openfda_pharm_class_moa":"nan","openfda_pharm_class_cs":"['Xanthines [CS]']","openfda_pharm_class_pe":"['Central Nervous System Stimulation [PE]']","openfda_pharm_class_epc":"['Central Nervous System Stimulant [EPC]', 'Methylxanthine [EPC]']","openfda_upc":"['0312843172531']","openfda_unii":"['362O9ITL9D', '3G6A5W338E', 'R35D29L3ZA']","openfda_rxcui":"(['1597298']","recalling_firm":"Bayer Healthcare, LLC","voluntary_mandated":"Voluntary: Firm initiated","state":"NJ","reason_for_recall":"Labeling: Label Mix-up: This recall was initiated after identifying that the label statement on the blister strip regarding the maximum number of capsules/caplets that should be taken within a 24-hour period, does not match the statement on the carton.","initial_firm_notification":"Letter","status":"Terminated","product_type":"Drugs","country":"United States","product_description":"Midol Complete, Acetaminophen, Caffeine, Pyrilamine Maleate, Gelcaps 24 ct. blister, OTC,  Distributed by Bayer Health Care, Morristown, NJ 07962   NDC 0280-8015-24","code_info":"NAA04K6 Exp. 09/13, NAA055P Exp. 09/13, NAA05PA Exp. 09/13","address_1":"36 Columbia Rd","address_2":"nan","product_quantity":"119,412 cartons"}
{"classification":"Class II","center_classification_date":"2020-04-13","report_date":"2020-04-22","postal_code":"08520-1401","termination_date":null,"recall_initiation_date":"2020-03-18","recall_number":"D-1231-2020","city":"East Windsor","more_code_info":"uau","event_id":85183,"distribution_pattern":"Nationwide within the United States","openfda_application_number":"['ANDA202800']","openfda_brand_name":"['ACETAMINOPHEN AND CODEINE PHOSPHATE']","openfda_dosage_form":null,"openfda_generic_name":"['ACETAMINOPHEN AND CODEINE PHOSPHATE']","openfda_manufacturer_name":"['Aurolife Pharma, LLC']","openfda_product_ndc":"['13107-058', '13107-059', '13107-060']","openfda_product_type":"['HUMAN PRESCRIPTION DRUG']","openfda_route":"['ORAL']","openfda_substance_name":"['ACETAMINOPHEN', 'CODEINE PHOSPHATE']","openfda_spl_id":"['57911bf7-78f8-4769-a257-6b12f6f69d3e']","openfda_spl_set_id":"['02386806-02d4-47e3-9c8b-7810146ee795']","openfda_pharm_class_moa":"nan","openfda_pharm_class_cs":"nan","openfda_pharm_class_pe":"nan","openfda_pharm_class_epc":"nan","openfda_upc":"nan","openfda_unii":"['362O9ITL9D', 'GSL05Y1MN6']","openfda_rxcui":"(['993770', '993781', '993890']","recalling_firm":"Aurobindo Pharma USA Inc.","voluntary_mandated":"Voluntary: Firm initiated","state":"NJ","reason_for_recall":"CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed","initial_firm_notification":"Letter","status":"Completed","product_type":"Drugs","country":"United States","product_description":"Acetaminophen and Codeine Phosphate Tablets, USP, 300 mg/60 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ 08810, NDC 13107-060-01","code_info":"Lot #:  060180017A, 060180019B1, 060180020A and 060180021A, Exp. Date 06/2021","address_1":"279 Princeton Hightstown Rd","address_2":"nan","product_quantity":"57337 units"}
{"classification":"Class II","center_classification_date":"2020-04-13","report_date":"2020-04-22","postal_code":"08520-1401","termination_date":null,"recall_initiation_date":"2020-03-18","recall_number":"D-1230-2020","city":"East Windsor","more_code_info":"uau","event_id":85183,"distribution_pattern":"Nationwide within the United States","openfda_application_number":"['ANDA202800']","openfda_brand_name":"['ACETAMINOPHEN AND CODEINE PHOSPHATE']","openfda_dosage_form":null,"openfda_generic_name":"['ACETAMINOPHEN AND CODEINE PHOSPHATE']","openfda_manufacturer_name":"['Aurolife Pharma, LLC']","openfda_product_ndc":"['13107-058', '13107-059', '13107-060']","openfda_product_type":"['HUMAN PRESCRIPTION DRUG']","openfda_route":"['ORAL']","openfda_substance_name":"['ACETAMINOPHEN', 'CODEINE PHOSPHATE']","openfda_spl_id":"['57911bf7-78f8-4769-a257-6b12f6f69d3e']","openfda_spl_set_id":"['02386806-02d4-47e3-9c8b-7810146ee795']","openfda_pharm_class_moa":"nan","openfda_pharm_class_cs":"nan","openfda_pharm_class_pe":"nan","openfda_pharm_class_epc":"nan","openfda_upc":"nan","openfda_unii":"['362O9ITL9D', 'GSL05Y1MN6']","openfda_rxcui":"(['993770', '993781', '993890']","recalling_firm":"Aurobindo Pharma USA Inc.","voluntary_mandated":"Voluntary: Firm initiated","state":"NJ","reason_for_recall":"CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed","initial_firm_notification":"Letter","status":"Completed","product_type":"Drugs","country":"United States","product_description":"Acetaminophen and Codeine Phosphate Tablets, USP, 300 mg/30 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ 08810, NDC 13107-059-99","code_info":"Lot #: 059180023A, 059180024A and 059180025A, Exp. Date 05/2021","address_1":"279 Princeton Hightstown Rd","address_2":"nan","product_quantity":"4332 units"}
